GSK confirms closure of agreement to divest anaesthesia portfolio …
GSK has divested its anaesthesia portfolio to Aspen (excluding the US and Canada which had been previously divested) for £180m plus milestones of up to £100m. Notes to editors: GSK’s anaesthesia portfolio consists of Ultiva, Nimbex, Tracrium, Mivacron and Anectine.
Products | Oncology | GSK US Medical Affairs
Find GSK US oncology product information: Prescribing Information, storage and handling, and more.
GSK Products | GSKPro for Healthcare Professionals
Explore the list of the GSK products available for use, view prescribing information, and access detailed Healthcare Professional websites.
GSK continues sell-off of non-core assets - BioPharma Dive
Sep 12, 2016 · GlaxoSmithKline announced Monday it will sell off non-core assets, continuing a strategy aimed at streamlining its business. The British pharma is selling its anesthesia business to Aspen Therapeutics for £180 million ($240 million) upfront plus £100 million ($133 million).
Vesalius Announces Multi-Target Strategic Alliance with GSK to …
1 day ago · "GSK brings numerous strengths to this alliance including its global scale and expertise in human genetics," said Amanda Kay, Ph.D., Senior Partner and Chief Business Development Officer, Flagship ...
Pipeline | Oncology | GSK US Medical Affairs
At GSK, our pipeline is focused on unlocking the science of the immune system, human genetics, and advanced technologies to develop vaccines and specialty medicines. Our products in development progress through three stages: phase I, phase II, and phase III/registrational.
GSK Oncology Pipeline
Our unique R&D approach of Science x Technology x Culture is helping to fight cancer on multiple groundbreaking fronts – focusing on maximizing survival through the discovery and development of novel oncology medicines that may have life-changing potential.
Clik-FIX ® Family of Catheter Securement Devices for Regional Anesthesia
Clik-FIX Catheter Securement Devices for regional anesthesia procedures are designed to reduce the risk of displacement and dislodgement. Using a universal catheter securement device for all epidural/PNB catheters can help encourage standardization of patient care. Displacement and dislodgement of epidural and PNB catheters can affect post ...
Securement Devices - bbraunusa.com
Clik-FIX® Family of Catheter Securement Devices for Regional Anesthesia. Designed to be low-profile, soft and secure. Products and Partnerships. Smart Infusion. IV Fluids and Irrigation Solutions. Needleless Products and Administration Sets. Smart Infusion Pumps. Vascular Access. Safe and Efficient Pharmacy.
GSK receives US FDA Breakthrough Therapy Designation for its B7 …
Aug 20, 2024 · GSK plc (LSE/NYSE: GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227), the Company’s investigational B7-H3-targeted antibody drug conjugate (ADC) being evaluated for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with ...
- Some results have been removed